Quick Answer
BIOTRICITY INC. reported Total Revenue of $13.79 million for fiscal year 2025.
BIOTRICITY INC. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $13.79M +14.3% |
$12.06M +25.2% |
$9.64M +26.0% |
$7.65M +126.0% |
$3.38M +138.7% |
$1.42M +256.0% |
| Revenue (ASC 606) | $13.79M +14.3% |
$12.06M +25.2% |
$9.64M +26.0% |
$7.65M +126.0% |
$3.38M +138.7% |
$1.42M +256.0% |
| Net Income | -$8.42M +40.3% |
-$14.09M +24.5% |
-$18.66M +35.9% |
-$29.13M -88.0% |
-$15.49M -40.0% |
-$11.07M -28.8% |
| Diluted EPS | -$0.56 +66.6% |
-$1.66 +26.4% |
-$2.26 | — | — | — |
| Total Assets | $5.64M -5.1% |
$5.94M -8.7% |
$6.51M -61.0% |
$16.68M +275.8% |
$4.44M +121.4% |
$2.00M +308.5% |
| Cash and Equivalents | $365.1K -53.5% |
$786.1K +37.8% |
$570.5K -95.3% |
$12.07M +448.1% |
$2.20M +131.8% |
$949.8K +1392.4% |
| Stockholders Equity | -$32.01M -1.7% |
-$31.47M -58.6% |
-$19.85M -825.3% |
-$2.14M +68.6% |
-$6.83M -127.7% |
-$3.00M -68.8% |
| R&D Expense | $2.16M -16.2% |
$2.57M -20.4% |
$3.23M +17.7% |
$2.74M +33.3% |
$2.06M +51.0% |
$1.36M +4.1% |
| Operating Income | -$2.45M +72.3% |
-$8.83M +42.7% |
-$15.41M +7.9% |
-$16.74M | — | — |
| Gross Profit | $10.56M +26.4% |
$8.36M +53.6% |
$5.44M +19.1% |
$4.57M +259.1% |
$1.27M +162.0% |
$485.8K +711.4% |
| Shares Outstanding | 26.08M +178.8% |
9.35M +9.9% |
8.51M -82.9% |
49.81M +37.9% |
36.12M +10.8% |
32.59M +5.0% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | December 31, 2025 | $3.99M | +10.2% | +2.6% |
| Revenue (ASC 606) | December 31, 2025 | $3.99M | +10.2% | +2.6% |
| Net Income | December 31, 2025 | -$717.1K | +41.7% | -3.8% |
| Diluted EPS | December 31, 2025 | -$0.04 | +22.2% | -44.8% |
| Total Assets | December 31, 2025 | $5.69M | -5.0% | -10.1% |
| Cash and Equivalents | December 31, 2025 | $256.4K | -49.7% | -16.9% |
| Stockholders Equity | December 31, 2025 | -$34.24M | -7.2% | -2.5% |
| R&D Expense | December 31, 2025 | $623.6K | +13.1% | +3.4% |
| Operating Income | December 31, 2025 | $440.9K | +360.9% | +61.0% |
| Gross Profit | December 31, 2025 | $3.25M | +17.6% | +2.2% |
| Shares Outstanding | December 31, 2025 | 27.81M | +14.0% | +3.8% |
- BIOTRICITY INC. reported Total Revenue of $13.79 million for fiscal year 2025.
- BIOTRICITY INC. showed an increase of +14.3% in Total Revenue compared to the prior fiscal year.
- BIOTRICITY INC. reported Revenue (ASC 606) of $13.79 million for fiscal year 2025.
- BIOTRICITY INC. showed an increase of +14.3% in Revenue (ASC 606) compared to the prior fiscal year.
- BIOTRICITY INC. reported Net Income of -$8.42 million for fiscal year 2025.
- BIOTRICITY INC. showed an increase of +40.3% in Net Income compared to the prior fiscal year.
- BIOTRICITY INC. reported Diluted EPS of $0.56 per share (loss) for fiscal year 2025.
- BIOTRICITY INC. showed an increase of +66.6% in Diluted EPS compared to the prior fiscal year.
- BIOTRICITY INC. reported Total Assets of $5.64 million for fiscal year 2025.
- BIOTRICITY INC. showed a decrease of -5.1% in Total Assets compared to the prior fiscal year.
- BIOTRICITY INC. reported Cash and Equivalents of $365.1 thousand for fiscal year 2025.
- BIOTRICITY INC. showed a decrease of -53.5% in Cash and Equivalents compared to the prior fiscal year.
- BIOTRICITY INC. reported Stockholders Equity of -$32.01 million for fiscal year 2025.
- BIOTRICITY INC. showed a decrease of -1.7% in Stockholders Equity compared to the prior fiscal year.
- BIOTRICITY INC. reported R&D Expense of $2.16 million for fiscal year 2025.
- BIOTRICITY INC. showed a decrease of -16.2% in R&D Expense compared to the prior fiscal year.
- BIOTRICITY INC. reported Operating Income of -$2.45 million for fiscal year 2025.
- BIOTRICITY INC. showed an increase of +72.3% in Operating Income compared to the prior fiscal year.
- BIOTRICITY INC. reported Gross Profit of $10.56 million for fiscal year 2025.
- BIOTRICITY INC. showed an increase of +26.4% in Gross Profit compared to the prior fiscal year.
- BIOTRICITY INC. reported Shares Outstanding of 26.08 million shares for fiscal year 2025.
- BIOTRICITY INC. showed an increase of +178.8% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: